BioTrinity 2017

London, UK

Monday, 8 May '17

Now in its 11th year, the aim of BioTrinity is simple - create an ideal networking and partnering platform for life science companies across the world to meet all under one roof, to ultimately help shape our healthcare future.

Chief Operating Officer, Dr Tom Mander will be presenting at the event and looks forward to discussing how Domainex can support your drug discovery programme.  If you would like to arrange a meeting with Tom at BioTrinity, please get in touch.

We look forward to seeing you there.